Alloimmunization to red blood cell (RBC) antigens represents a challenge for physicians
caring for women of child bearing potential. Exposure to non-self RBC antigens may occur …

Background: Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of
fetus and newborn (HDFN) aims to guide clinicians and the immunized women to focus on …

Introduction Hemolytic disease of the fetus and newborn (HDFN) is a condition caused by
maternal alloantibodies against fetal red blood cells (RBCs) that can cause severe morbidity …

Introduction: The advent of affordable and rapid next-generation sequencing has been
transformative for prenatal diagnosis. Sequencing of cell-free DNA in maternal plasma has …

Background RhD is the most important and complex blood group system because of its
highly polymorphic and immunogenic nature. RhD variants can induce immune response by …

BACKGROUND Fetuses whose mothers have produced antibodies to red blood cell (RBC)
or platelet antigens are at risk of being affected by hemolytic disease or alloimmune …

Immunization against RhD is the major cause of hemolytic disease of the fetus and newborn
(HDFN), which causes fetal or neonatal death. The introduction of postnatal immune …

The discovery of the giant magnetoresistance (GMR) effect has stimulated significant
progress both in the theory of electronic transport in metallic layered structures and in …

Introduction: ABO blood group incompatibility between a pregnant woman and her fetus as a
cause of morbidity or mortality of the fetus or newborn remains an important, albeit rare, risk …

Abstract Background and Objectives Non‐invasive assays for predicting foetal blood group
status in pregnancy serve as valuable clinical tools in the management of pregnancies at …